50 firms object Greece's new medicine prices
This article was originally published in Scrip
Pharmaceutical firms are not happy with the way the Greek government is cutting €1.2 billion off its drugs bill as part of a wider fiscal crisis. Some 50 of the 200-odd firms in the country are objecting to the drug prices spelled out in the price bulletin that was published earlier this month. Scrip had learnt the figure from the ministry of economy, competitiveness and shipping.